United States · FDA National Drug Code directory
Relistor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65649-551_9db15b8c-2928-4b75-a33b-548416afc8c9
- Product NDC
- 65649-551
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Methylnaltrexone bromide
- Labeler
- Salix Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080424
- Source listing expiry
- 20271231
Source-listed ingredients
- METHYLNALTREXONE BROMIDE — 12 mg/.6mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (65649-551-02) / .6 mL in 1 VIAL, SINGLE-DOSE · 65649-551-02
- 7 BLISTER PACK in 1 CARTON (65649-551-03) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE · 65649-551-03
- 1 BLISTER PACK in 1 CARTON (65649-551-07) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE · 65649-551-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →